Explore /
Poster
/ A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with <em>BRCA1/2</em> gene alterations (NePtune).

A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).

Authors

Rana R. McKay

University of California, San Diego Health, La Jolla, CA

Rana R. McKay , Lin Liu , Minya Pu , Arlene Araneta , Kit L. Yuen , Jennifer Gomez , Neremiah Castano , Archana Ajmera , Huihui Ye , Roberto Pili , Karie Runcie , Deaglan Joseph McHugh , Kenneth Offit , Channing Judith Paller , Naomi B. Haas , Juan Javier-Desloges , Christopher J. Kane , Tyler M Seibert , Aditya Bagrodia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT05498272

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS5128)

DOI

10.1200/JCO.2024.42.16_suppl.TPS5128

Abstract #

TPS5128

Poster Bd #

523b

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium